Minegishi Y - Search Results

1

Osimertinib plus local treatment for brain metastases versus osimertinib alone in patients with EGFR-Mutant Non-Small Cell Lung Cancer.

Tozuka T, Noro R, Mizutani H, Kurimoto F, Hakozaki T, Hisakane K, Naito T, Takahashi S, Taniuchi N, Yajima C, Hosomi Y, Hirose T, Minegishi Y, Okano T, Kamio K, Yamaguchi T, Seike M; East Japan Chesters Group. Tozuka T, et al. Among authors: minegishi y. Lung Cancer. 2024 May;191:107540. doi: 10.1016/j.lungcan.2024.107540. Epub 2024 Mar 24. Lung Cancer. 2024. PMID: 38614069

2

Reduction of PTEN protein and loss of epidermal growth factor receptor gene mutation in lung cancer with natural resistance to gefitinib (IRESSA).

Kokubo Y, Gemma A, Noro R, Seike M, Kataoka K, Matsuda K, Okano T, Minegishi Y, Yoshimura A, Shibuya M, Kudoh S. Kokubo Y, et al. Among authors: minegishi y. Br J Cancer. 2005 May 9;92(9):1711-9. doi: 10.1038/sj.bjc.6602559. Br J Cancer. 2005. PMID: 15870831 Free PMC article.

3

Anticancer drug clustering in lung cancer based on gene expression profiles and sensitivity database.

Gemma A, Li C, Sugiyama Y, Matsuda K, Seike Y, Kosaihira S, Minegishi Y, Noro R, Nara M, Seike M, Yoshimura A, Shionoya A, Kawakami A, Ogawa N, Uesaka H, Kudoh S. Gemma A, et al. Among authors: minegishi y. BMC Cancer. 2006 Jun 30;6:174. doi: 10.1186/1471-2407-6-174. BMC Cancer. 2006. PMID: 16813650 Free PMC article.

4

Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancer.

Gemma A, Seike M, Kosaihira S, Minegishi Y, Noro R, Nara M, Hosomi Y, Okano T, Kokubo Y, Yoshimura A, Shibuya M, Kudoh S. Gemma A, et al. Among authors: minegishi y. Anticancer Res. 2006 Jul-Aug;26(4B):3083-7. Anticancer Res. 2006. PMID: 16886638 Free article. Clinical Trial.

5

Gefitinib (IRESSA) sensitive lung cancer cell lines show phosphorylation of Akt without ligand stimulation.

Noro R, Gemma A, Kosaihira S, Kokubo Y, Chen M, Seike M, Kataoka K, Matsuda K, Okano T, Minegishi Y, Yoshimura A, Kudoh S. Noro R, et al. Among authors: minegishi y. BMC Cancer. 2006 Dec 6;6:277. doi: 10.1186/1471-2407-6-277. BMC Cancer. 2006. PMID: 17150102 Free PMC article.

6

In vitro simulation study of individualized chemotherapy in lung cancer.

Li C, Gemma A, Minegishi Y, Matsuda K, Seike Y, Noro R, Shionoya A, Kawakami A, Ogawa N, Kudoh S. Li C, et al. Among authors: minegishi y. J Nippon Med Sch. 2007 Jun;74(3):217-22. doi: 10.1272/jnms.74.217. J Nippon Med Sch. 2007. PMID: 17625370 Free article.

7

PTEN inactivation in lung cancer cells and the effect of its recovery on treatment with epidermal growth factor receptor tyrosine kinase inhibitors.

Noro R, Gemma A, Miyanaga A, Kosaihira S, Minegishi Y, Nara M, Kokubo Y, Seike M, Kataoka K, Matsuda K, Okano T, Yoshimura A, Kudoh S. Noro R, et al. Among authors: minegishi y. Int J Oncol. 2007 Nov;31(5):1157-63. Int J Oncol. 2007. PMID: 17912443

8

Gemcitabine resistance in a highly metastatic subpopulation of a pulmonary adenocarcinoma cell line resistant to gefitinib.

Takemura A, Gemma A, Shibuya M, Matsuda K, Okano T, Nara M, Noro R, Minegishi Y, Yoshimura A, Kudoh S. Takemura A, et al. Among authors: minegishi y. Int J Oncol. 2007 Dec;31(6):1325-32. Int J Oncol. 2007. PMID: 17982658

9

E-cadherin expression and epidermal growth factor receptor mutation status predict outcome in non-small cell lung cancer patients treated with gefitinib.

Miyanaga A, Gemma A, Ando M, Kosaihira S, Noro R, Minegishi Y, Kataoka K, Nara M, Okano T, Miyazawa H, Tanaka T, Yoshimura A, Kobayashi K, Iwanami H, Hagiwara K, Tsuboi E, Kudoh S. Miyanaga A, et al. Among authors: minegishi y. Oncol Rep. 2008 Feb;19(2):377-83. Oncol Rep. 2008. PMID: 18202784

10

The anticancer effect of histone deacetylase inhibitors and combination with the cytotoxic agents in lung cancer cells: biological analyses for future clinical application.

Noro R, Miyanaga A, Shimokawa T, Kuribayashi H, Mizutani H, Minegishi Y, Okano T, Seike M, Soeno C, Kataoka K, Matsuda K, Yoshimura A, Gemma A. Noro R, et al. Among authors: minegishi y. J Nippon Med Sch. 2009 Feb;76(1):44-6. doi: 10.1272/jnms.76.44. J Nippon Med Sch. 2009. PMID: 19305113 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

397 results

Search Page

Filters